Staphylococcus aureus Bacteremia in Children of Rural Areas of The Gambia, 2008-2015

Emerg Infect Dis. 2019 Apr;25(4):701-709. doi: 10.3201/eid2504.180935.

Abstract

Staphylococcus aureus bacteremia is a substantial cause of childhood disease and death, but few studies have described its epidemiology in developing countries. Using a population-based surveillance system for pneumonia, sepsis, and meningitis, we estimated S. aureus bacteremia incidence and the case-fatality ratio in children <5 years of age in 2 regions in the eastern part of The Gambia during 2008-2015. Among 33,060 children with suspected pneumonia, sepsis, or meningitis, we performed blood culture for 27,851; of 1,130 patients with bacteremia, 198 (17.5%) were positive for S. aureus. S. aureus bacteremia incidence was 78 (95% CI 67-91) cases/100,000 person-years in children <5 years of age and 2,080 (95% CI 1,621-2,627) cases/100,000 person-years in neonates. Incidence did not change after introduction of the pneumococcal conjugate vaccine. The case-fatality ratio was 14.1% (95% CI 9.6%-19.8%). Interventions are needed to reduce the S. aureus bacteremia burden in The Gambia, particularly among neonates.

Keywords: Staphylococcus aureus; The Gambia; bacteremia; bacteria; case-fatality ratio; children; epidemiology; fatality; incidence; infants; invasive bacterial disease; meningitis/encephalitis; neonates; pneumococcal conjugate vaccine; pneumonia; sepsis; surveillance.

Publication types

  • Historical Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteremia*
  • Child, Preschool
  • Disease Management
  • Female
  • Gambia / epidemiology
  • History, 21st Century
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Pneumococcal Vaccines / administration & dosage
  • Pneumococcal Vaccines / immunology
  • Population Surveillance
  • Risk Factors
  • Rural Population*
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / history
  • Staphylococcal Infections / microbiology*
  • Staphylococcal Infections / prevention & control
  • Staphylococcus aureus*

Substances

  • Pneumococcal Vaccines